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1003dyskinesis following anterior ST-segment elevation
myocardial infarction. This study takes advantage of
a patient population with consistent follow-up within
the same regional health system, managed at a high-
volume academic center, and participating in a
detailed prospective clinical database. In reviewing
the report, however, we were left with a few ques-
tions; the answers to which might be of interest to
other readers.
First, it is not clear to us from our reading of the
paper how the propensity score was derived, for what
clinical parameter propensity was determined (i.e.,
propensity for TATT vs. propensity for net adverse
clinical events) (2), or how the propensity score was
used to determine the net adverse clinical events
odds ratio reported for warfarin therapy. Was this
also part of the inverse-probability weighting multi-
variable regression analysis?
Second, and somewhat related, it would seem,
from the data presented, that anticoagulation with
warfarin for apical dysfunction is the exception rather
than the rule at this particular institution, with fewer
patients treated and with TATT patients having more
apical dysfunction, worse ejection fractions, and a 3-
fold higher rate of cardiogenic shock. As such, we are
left to wonder whether this retrospective analysis
suffers from intractable confounding, which would
explain the apparent paradoxical increase in non-
hemorrhagic events in this group.
Finally, we would ask the authors to comment on
both the timing of adverse bleeding events prior to
hospital discharge (post-procedure vs. post-initiation
of warfarin) and the decision to include these in the
primary analysis. It would stand to reason that most
patients in this group did not have a therapeutic In-
ternational Normalized Ratio until the last day or 2 of
hospitalization. A “back of the envelope” calculation
suggests that the exclusion of in-hospital events
would make the difference in outcomes between the 2
groups considerably less dramatic. Would a land-
marked analysis from the time of discharge have also
achieved statistical signiﬁcance?*Brian J. Potter, MDCM, MSc
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2012;5:692.The Imperfections and
Perils of Procedure-Based
Risk ScoresSherwood et al. (1) report that groups that perform
more high-risk percutaneous coronary interventions
have similar risk-adjusted mortality to those who
perform fewer. The data are interesting, but a number
of limitations preclude the ﬁnal conclusion that
adopting a more aggressive practice pattern will not
increase risk-adjusted mortality.
Subgroups do not have uniform risk. Patients in
cardiogenic shock have mortality rates that range
from 22% to 88% (2). Physicians preferentially treat
patients at the lower spectrum of risk and thus will
have lower observed mortality than predicted by risk
scores. At the same time, motivated practitioners
have an incentive to “up-code,” which artiﬁcially
inﬂates the estimated risk. The fact that in Sherwood
et al. (1), “high-risk” cases tended to have lower-
than-expected mortality is consistent with these
limitations.
The conclusion also assumes that risk-averse op-
erators are as adept as those who regularly perform
high-risk cases. One of the beneﬁts touted for public
reporting is that it directs higher-risk cases towards
superior operators (3).
A ﬁnal limitation is the exclusion of patients who
receive angioplasty at one site, but are then trans-
ferred to a different site. This excludes high-risk pa-
tients and procedural complications that might
signiﬁcantly alter the ﬁnal results.
These limitations were not present at a Canadian
regional care center, free of the medico-legal and
public reporting concerns of the United States. In this
setting, regional efforts to more aggressively treat
high-risk myocardial infarction patients led to an in-
crease in risk-adjusted mortality despite evidence for
preserved procedural quality (4).
This debate also distracts from the more important
issue. The real question is whether risk aversion re-
lated to public reporting results in public harm. This
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1004analysis must include, not only those who undergo
the procedure, but also those in whom the procedure
was deferred. In 2012, Joynt et al. attempted to answer
this question by exploring the outcomes of all patients
with myocardial infarction in states that adopted
public reporting, compared with those that did not.
They found that in states with public reporting,
mortality rates were signiﬁcantly higher for patients
presenting with ST-segment elevation myocardial
infarction (p ¼ 0.004) with a trend toward worse
outcomes for the larger cohort of all patients with
myocardial infarction (p ¼ 0.10). More recently, this
same approach was applied to a much larger popula-
tion, revealing a dramatic 21% increase in mortality
for patients presenting with myocardial infarction in
states with public reporting (p ¼ 0.013) (5). This was
driven primarily by an increase in mortality in pa-
tients in whom intervention was deferred. With these
results, we must conclude that public reporting of
procedural outcomes results in public harm.
We applaud Sherwood et al. (1) for their efforts. At
the same time, we wonder whether the time has come
to move away from procedure-based risk scores and
toward diagnosis-based databases that examine the
outcomes of all patients, not just those subgroups
selected to undergo speciﬁc procedures.*Steve Miner, MD
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Closure Guided by
Personalized 3D-Printed
Cardiac ReconstructionPercutaneous left atrial appendage occlusion (LAAO)
with the Watchman device (Boston Scientiﬁc, Natick,
Massachusetts) is currently conducted under ﬂuoro-
scopic and transesophageal echocardiographic guid-
ance. Multidetector computed tomography (MDCT)
acquires a 3-dimensional (3D) dataset that provides
better spatial resolution, allows unlimited recon-
struction, and enables more precise procedural
planning than 2-dimensional (2D) imaging (1,2).
Nevertheless, the complex dimensions of the left atrial
appendage and its variable morphology may result in
procedural failure despite careful planning (3).
Three-dimensional printing (also known as rapid
prototyping) allows an exact replica of a patient’s
anatomy to be created in a variety of materials, which
may replicate underlying tissue characteristics. We
describe the use of a patient-speciﬁc model to guide a
left atrial occlusion procedure using the Watchman
device.
A 74-year-old man with a history of paroxysmal
atrial ﬁbrillation and a CHA2DS2VASc score of 6, ce-
rebrovascular events, ischemic cardiomyopathy, and
intolerance of anticoagulation was referred to our
institution for consideration of transcatheter LAAO.
In preparation for the procedure, MDCT of the left
atrium and left atrial appendage, gated to atrial
diastole, was performed. Semiautomated segmenta-
tion (Mimics v17.0, Materialise Software, Leuven,
Belgium) generated a stereolithography ﬁle that was
printed in a rubber-like material to simulate atrial
mechanical properties (Tango Plus Material, Shore
hardness 27A, Stratasys Objet Connex 500 printer,
Stratasys, Eden Prairie, Minnesota). Watchman de-
vices in sizes of 21 mm, 24 mm, and 27 mm were
placed in the model, which was reimaged using clin-
ical CT. Virtual rendered images were generated us-
ing Ziostation (Qi Imaging, Redwood City, California)
(Figure 1A).
The imaged 3D printed replica atrial appendage
with the devices in situ (Figure 1D) was analyzed
(3-Matic 9.0, Materialise Software), and the anatomic
deformation was calculated for each device, creating
a 3D map color-coded according to the degree of
deformation caused. This demonstrated the areas and
extent of engagement of the device on the ﬂexible
atrial model.
